4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-016854
President and CEO sold 18,334 shares at an average $66.35 ($1,216,551)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −3,370 | $64.42 | $217,106 | 2,320,706 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −5,885 | $65.63 | $386,209 | 2,314,821 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −3,453 | $66.55 | $229,780 | 2,311,368 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −3,339 | $67.69 | $226,017 | 2,308,029 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −1,625 | $68.46 | $111,246 | 2,306,404 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −594 | $69.65 | $41,371 | 2,305,810 | I |
| Watts Ryan J. President and CEO | 2021-03-01 | Sale | −68 | $70.92 | $4,823 | 2,305,742 | I |
| Open-market sales · 18,334 sh · avg $66.35 · $1,216,551 | |||||||
Loading xslF345X03/doc4.xml…